Pharma & Biotech

Viking Therapeutics shares continue to face significant downward momentum amid persistent selling activity. Despite the company's advanced clinical development programs,...

Eli Lilly and Company has achieved two significant regulatory approvals that promise to accelerate the pharmaceutical giant's expansion within its...

The biotechnology sector offers little mercy to struggling companies, and Ocugen finds itself in precisely that position. With investor confidence...

Innoviva shares are approaching a critical juncture, with two significant near-term events poised to shape the biopharmaceutical company's trajectory. Despite...

After a prolonged period of underwhelming performance, Arcturus Therapeutics has staged a remarkable market recovery. The biotech firm's shares experienced...

The biopharmaceutical firm Exelixis is generating significant attention with its developmental cancer treatment, Zanzalintinib. While the company already markets CABOMETYX...

Arvinas investors are bracing for what could prove to be the most consequential week of the year for the biotechnology...

Biotechnology firm Denali Therapeutics has encountered a significant regulatory hurdle. The U.S. Food and Drug Administration has postponed its decision...

The equity value of Anika Therapeutics is caught in a pronounced downward trend. Following a substantial price decline on Friday,...

Seres Therapeutics finds itself at a critical crossroads, implementing severe workforce reductions while simultaneously advancing a promising clinical program. The...